Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 1 month ago
Duration: 0h 3m 31s
Pharma cos may see short-term price blip: Ind-Ra
Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra).
The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.
Uploaded by: Rediff Video Desk on Wed, 27 Aug 2025 11:28:12 +0530
Views: 100
Tags: Pharma cos may see short-term price blip: Ind-Ra
© 2025